The Brightest Minds in GLP-1 Science — In Your Pocket
Stay on top of the latest in GLP-1 research with expert insights on clinical care, how it works, and where the science is headed. Built to keep you informed, grounded in the evidence, and prepared for what's next.
About The Podcast
Conversations That Move the Field Forward
Join leading endocrinologists, researchers, and healthcare decision-makers for real talk on the latest in GLP-1 research. Each episode brings practical insights, clinical updates, and expert takes that are helping shape the future of obesity treatment.
From breakthrough mechanisms to real-world application, we give you the knowledge you need to stay sharp and stay ahead in GLP-1 science and patient care.
Here's What You'll Find
- Fresh results from clinical trials and real-world studies
- Expert insights into the mechanisms of action of GLP-1
- Up-to-date guidance on dosing approaches and shifting treatment guidelines
Meet the Hosts
Learn from the brightest minds in GLP-1 science, clinical research, and innovation who are shaping the future of obesity treatment
Dr. Stefan Trapp
- Professor of Autonomic Neuroscience, University College London
- Founder, Centre for Cardiovascular and Metabolic Neuroscience
- PhD in Neuroscience, University of Göttingen
- Leading Investigator in Brain-Produced GLP-1 Research
Ms. Areesha Moiz
- Health Researcher, Clinical & Translational Science, McGill University
- Expert in Epidemiology and Evidence Synthesis
- Published Research on GLP-1 Agonists in Leading Medical Journals
- Bridging Complex Science and Clear Public Communication
Latest Episodes
Catch up on recent conversations with world-leading GLP-1 researchers
Dr. Jens Juul Holst: GLP-1 in Modern Medicine
Dr. Jens Juul Holst, Professor of Medical Physiology at the University of Copenhagen, joins host Areesha Moiz to discuss the discovery and development of GLP-1-based therapies.
Dr. Michael Nauck: GLP-1 Origins
Dr. Michael Nauck, Head of Clinical Research at the Diabetes Division, St. Josef-Hospital, Ruhr-University Bochum, speaks with Areesha Moiz about the origins, evolution, and therapeutic potential of incretin hormones.
Dr. Michael Schwartz: GLP-1 and Brain Pathways
Dr. Michael Schwartz, Robert H. Williams Endowed Chair and Professor of Medicine at the University of Washington, speaks with Areesha Moiz about how GLP-1 receptor agonists reshape obesity treatment.
Join the Top 1% in GLP-1 Care
Learn from world-class conversations with leading endocrinologists, metabolic researchers, and healthcare innovators. This podcast is your trusted source for staying updated on the latest in GLP-1 science, clinical strategies, and breakthrough treatments.
Cutting-Edge Research
Hear straight from the experts about new discoveries in GLP-1 pathways, pharmacology, and how patients are responding.
Real-World Clinical Impact
Find out how leading clinicians are fine-tuning GLP-1 protocols using real-world data to boost patient outcomes.
What's Next in Treatment
Keep up with the newest tech, bold ideas, and how GLP-1s are changing the game in obesity treatment.
Never Miss an Episode
Subscribe to receive updates on new episodes, exclusive insights, and the latest from the world's leading experts in GLP-1 science and obesity treatment.
- Monthly episode updates
- Early access to new research
Trusted and supported by innovative companies like
